Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Single Arm Study of Palbociclib in Patients With Metastatic HER2-positive Breast Cancer With Brain Metastasis

NCT02774681 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT02774681
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02774681 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Single Arm Study of Palbociclib in Patients With Metastatic HER2-positive Breast Cancer With Brain Metastasis
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2016
Completion date
February 16, 2020
Enrollment
12 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma metastatic in the brain, estrogen receptor negative, her2/neu negative, her2/neu positive, progesterone receptor negative, recurrent breast carcinoma, stage iv breast cancer